Inhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL6 Mice

Abstract EN

Immunomodulatory effect has been found to be an important therapeutic measure for immune responses against cancer.

In this study, we evaluated the inhibition of Scutellaria barbata D.

Don (SB), an anti-inflammatory and an antitumor Chinese herb, including flavonoids and scutebarbatines on tumor growth and its immunomodulatory effects in vivo.

HPLC and LC/MS/MS methods were conducted for the analysis of flavonoids and scutebarbatines in SB.

Lewis-bearing C57BL/6 mice model was established and tumor volume was evaluated by high frequency color ultrasound experiment.

ELISA and western blot analysis were performed for the determination of immunomodulatory factors.

SB treatment at the dose of 10, 6.67, and 3.33 g crude drug/kg/d significantly inhibited tumor growth of Lewis-bearing C57BL/6 mice with the inhibition rates of 44.41±5.44%, 33.56±4.85%, and 27.57±4.96%, respectively.

More importantly, the spleen and thymus indexes were increased remarkably by SB treatment.

SB could decrease IL-17, IL-10, FOXP3, TGF-β1, RORγt, and IL-6 levels whereas it could increase remarkably IL-2 and IFN-γ levels.

Our results demonstrated that SB could inhibit tumor growth in vivo through regulating immune function in tumor-bearing mice and suggested that the immunomodulatory function of SB had a potential therapeutic effect in lung cancer.